Current Status of Catheter Ablation for Atrial Fibrillation - Updated Summary of the Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
Current Status of Catheter Ablation for Atrial Fibrillation - Updated Summary of the Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
复制标题
DOI：
10.1253/circj.cj-13-1179
复制
发表时间：
2014-05-01
影响因子：
3.3
通讯作者：
Okumura, Ken
中科院分区：
文献类型：
--
作者：
Inoue, Koichi;Murakawa, Yuji;Okumura, Ken
背景：本研究的目的是提供日本房颤导管消融治疗现状的准确数据。方法和结果：日本心脏节律学会要求会员对2011年9月、2012年3月和2012年9月进行的房颤消融进行回顾性登记。共有165个中心提交了3373名患者的数据(年龄，62+/-11岁；男性，76.1%；阵发性房颤，64.4%)。97.5%的患者行肺静脉隔离(PVI)，77.4%的患者行额外消融。94.8%的患者使用了三维标测系统，87.7%的患者使用了冲洗尖端导管。尽管CHADS(2)评分平均为1.0+/-1.0，但大多数患者在手术期间和之后接受了口服抗凝剂(OAC)治疗(分别为69.8%和97%)。然而，维生素K拮抗剂(VKA)处方减少(第1次调查与第3次调查相比，分别为59.3%与47.8%，81.7%与55.2%，P
Background: The purpose of this study was to provide precise data on the current status of catheter ablation for atrial fibrillation (AF) in Japan.Methods and Results: The Japanese Heart Rhythm Society requested that members retrospectively register data for AF ablation performed in September 2011, March 2012, and September 2012. A total of 165 centers submitted data for 3,373 patients (age, 62 +/- 11 years; male, 76.1%; paroxysmal AF, 64.4%). Pulmonary vein isolation (PVI) and additional ablation were performed in 97.5% and 77.4% of patients, respectively. 3-D mapping systems and irrigated-tip catheters were used in 94.8% and 87.7% of the patients, respectively. Although the mean CHADS(2) score was 1.0 +/- 1.0, the majority received oral anticoagulant (OAC) during and following the procedure (69.8% and 97%, respectively). Vitamin K antagonist (VKA) prescription, however, decreased (1st vs. 3rd survey, during and following the procedure, 59.3% vs. 47.8% and 81.7% vs. 55.2%, respectively, P